The policy change affects funding under programs such as ESSER (Elementary and Secondary School Emergency Relief), ARPA, and ...

My ill-fated trip to Morocco in 2019 put the final nail in the coffin of my romantic relationship and a nasty dent in my ...

Healthcare services company Chemed Corporation (NYSE:CHE) in Q4 CY2024, with sales up 9.2% year on year to $640 million. Its ...

Net Sales Grew 7% Year-Over-Year for the Fourth Quarter and 9% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were ...

Michael K. McGarrity, Chief Executive Officer and Ron Kalfus, Chief Financial Officer, will host a conference call and Q&A session today at 4:30 PM EST / 22:30 CET. The call will be conducted in ...

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest ...

We like the Travel Guard Deluxe policy for people who don’t require high travel medical expense limits but instead want the ...

Integrating ICHRAs into your employee benefits strategy can significantly enhance job satisfaction, retention, and engagement ...

BioCryst Pharmaceuticals, a rare disease biotech, shows strong revenue growth from ORLADEYO and a healthy cash position. See ...

Fourth quarter 2024 net revenue from global sales of IMCIVREE® (setmelanotide) of $41.8 million ---- On track to report topline data from ...

Q4 2024 Earnings Conference Call February 25, 2025 5:00 PM ETCompany ParticipantsRyan Peterson – Investor RelationsKevin Smith ...

On track to provide clinical data from the 12 mg dose cohort from the Phase 1b PIONEER trial of pociredir in SCD in mid-2025 and the 20 mg dose ...